- Home
- MDGL vs ENLT Comparison
MDGL vs ENLT Comparison
Compare MDGL & ENLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MDGL | ENLT |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 12.1B |
| IPO Year | 2005 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MDGL | ENLT |
|---|---|---|
| Price | $542.61 | $77.46 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $674.45 | $48.83 |
| AVG Volume (30 Days) | ★ 246.5K | 152.8K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $180,133,000.00 | N/A |
| Revenue This Year | $58.39 | $403.69 |
| Revenue Next Year | $48.55 | N/A |
| P/E Ratio | ★ N/A | $76.10 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $393.61 | $28.03 |
| 52 Week High | $615.00 | $108.65 |
Technical Indicators
Market Signals| Indicator | MDGL | ENLT |
|---|---|---|
| Relative Strength Index (RSI) | 55.57 | 43.31 |
| Support Level | $529.02 | $65.61 |
| Resistance Level | $545.13 | $79.81 |
| Average True Range (ATR) | 17.76 | 1.97 |
| MACD | 2.63 | -0.27 |
| Stochastic Oscillator | 78.60 | 28.72 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About ENLT Enlight Renewable Energy Ltd.
Enlight Renewable Energy Ltd develops, finances, constructs, owns, and operates utility-scale renewable energy projects. The company's operating segments are the MENA segment, Europe segment, U.S.A segment, and Others. It generates the majority of its revenue from the Europe segment, producing its revenue from the sale of the electricity which is produced through wind energy and solar energy in Europe.